Johnson & Johnson
Johnson & Johnson (JNJ) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · JNJ · as of Sep 30, 2024
Ownership Breakdown
3,999
Institutional Holders
▲ 79 vs Q2
$279.57B
Total Inst. Value
▲ $30.23B vs Q2
2.41B
Shares Outstanding
freeFloat 99.84%
1.72B
13F Shares Held
▲ 15.11M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
JNJ largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 231.02M | 9.60% | 9.60% | $37.44T | Nov 13, 2024 | ▲ 1.98M |
BLACKROCK, INC. pharmaceutical preparations | 199.95M | 8.31% | 8.31% | $32.40T | Nov 13, 2024 | NEW |
STATE STREET CORP pharmaceutical preparations | 134.25M | 5.58% | 5.58% | $21.76T | Nov 14, 2024 | ▲ 1.15M |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 56.11M | 2.33% | 2.33% | $9.06T | Nov 12, 2024 | ▲ 1.00M |
MORGAN STANLEY pharmaceutical preparations | 45.16M | 1.86% | 1.86% | $7.32T | May 14, 2025 | ▲ 3.09M |
JPMORGAN CHASE & CO pharmaceutical preparations | 34.36M | 1.43% | 1.43% | $5.57T | Dec 26, 2024 | ▲ 4.52M |
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO pharmaceutical preparations | 31.68M | 1.32% | 1.32% | $5.13T | Nov 12, 2024 | — held |
NORGES BANK pharmaceutical preparations | 29.04M | 1.20% | 1.20% | $4.71T | Nov 12, 2025 | ▼ 52.2K |
NORTHERN TRUST CORP pharmaceutical preparations | 27.45M | 1.14% | 1.14% | $4.45T | Nov 13, 2024 | ▼ 980.1K |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 25.16M | 1.05% | 1.05% | $4.08T | Nov 14, 2024 | ▲ 251.3K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
34
Increased
+28.81M shares1
New Positions
first time holders14
Decreased
−8.20M shares0
Sold Out
fully exitedNet shares change (top 50)
+20.61M
+28.81M / −8.20M
Net new holders
+21
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
JNJ insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
91
Buy transactions
119
Sell transactions
0.76
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
REED JOHN C EVP, Innovative Medicine, R&D | May 1, 2026 | Tax Withhold | 11,002 | $229.85 | $2.53M | 24.9K | Form 4 ↗ |
Woods Eugene A. director | Apr 23, 2026 | Award | 975 | — | — | 6.2K | Form 4 ↗ |
West Nadja director | Apr 23, 2026 | Award | 975 | — | — | 7.7K | Form 4 ↗ |
WEINBERGER MARK A director | Apr 23, 2026 | Award | 975 | — | — | 12.0K | Form 4 ↗ |
Pinto Daniel E director | Apr 23, 2026 | Award | 1,712 | — | — | 2.2K | Form 4 ↗ |
MORIKIS JOHN G director | Apr 23, 2026 | Award | 1,540 | — | — | 1.5K | Form 4 ↗ |
McClellan Mark B. director | Apr 23, 2026 | Award | 975 | — | — | 21.3K | Form 4 ↗ |
Joly Hubert director | Apr 23, 2026 | Award | 975 | — | — | 9.2K | Form 4 ↗ |
Johnson Paula A director | Apr 23, 2026 | Award | 975 | — | — | 5.4K | Form 4 ↗ |
HEWSON MARILLYN A director | Apr 23, 2026 | Award | 975 | — | — | 15.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Johnson & Johnson (JNJ) is primarily owned by institutional investors, who hold approximately 71.5% of total shares outstanding. Company insiders own approximately 0.16%, while retail and public investors account for the remaining 28.33%.
The largest institutional shareholder of Johnson & Johnson is VANGUARD GROUP INC, holding approximately 231.02 million shares — equal to 9.60% of outstanding shares — as of September 30, 2024.
A total of 3,999 institutional investors currently hold JNJ stock, with a combined institutional value of approximately $279.57 billion as of the most recent 13F filing period.
Frequently asked questions
JNJ ownershipJohnson & Johnson (JNJ) is primarily owned by institutional investors, who hold approximately 71.5% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.60% stake. Company insiders hold 0.16%. Data sourced from SEC Form 13F as of September 30, 2024.